Drugmakers to Sell Popular Blood Thinner Eliquis at 40% Discount

Drugmakers Pfizer Inc. and Bristol-Myers Squibb Co. will start selling their popular blood thinner Eliquis directly to patients at a cash-pay price of $346 a month.

Beginning Sept. 8, patients will be able to purchase the drug directly through Eliquis 360 Support, the drugmakers said in a statement on Thursday.

The discounted price is 40% lower than the US list price, Bristol said, but it’s higher than the one the Biden administration negotiated last year under the Inflation Reduction Act, a law that gives the government power to negotiate prices through Medicare. Beginning in 2026, the drug will cost $231 ...